In line with reduced overall frequencies we found reduced frequencies of IFN-γ expressing Tc cells in Ofa treated MS patients (p<0.05; Figure 6A), while IL-2, IFN-g/IL-2 and IL-17 expressing Tc cells did not differ (Figures 6B–D). This evidence concerns the gene IL2 and myeloid sarcoma.